Douglass Winthrop Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,206
Closed -$335K 276
2021
Q3
$335K Sell
10,206
-101,200
-91% -$3.24M 0.01% 229
2021
Q2
$3.37M Buy
+111,406
New +$3.67M 0.08% 83

Other funds holding OGN

Douglass Winthrop Advisors's OGN Position: Q4 2021 in Review

Douglass Winthrop Advisors sold out of Organon & Co (OGN) in Q4 2021, closing a stake of 10,206 shares — an estimated $335K sold.

Douglass Winthrop Advisors first reported a position in OGN in Q2 2021 and held it in 2 quarters. The position peaked at $3.37M in Q2 2021. 907 funds tracked by Wall St. Rank hold OGN as of Q4 2021.

  • Douglass Winthrop Advisors reported no remaining Organon & Co position as of Q4 2021 after selling out during the quarter.
  • Douglass Winthrop Advisors sold 10,206 Organon & Co shares in Q4 2021, an estimated $335K.
  • Douglass Winthrop Advisors first reported a position in Organon & Co in Q2 2021 and held it in 2 quarters.
  • Douglass Winthrop Advisors's Organon & Co position peaked at $3.37M in Q2 2021.
  • 907 funds tracked by Wall St. Rank held Organon & Co as of Q4 2021.

Based on Douglass Winthrop Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.